Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
165 hedge funds and large institutions have $733M invested in Spectrum Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 27 reducing their positions, and 23 closing their positions.
204% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 27
5% less funds holding
Funds holding: 173 → 165 (-8)
17% less capital invested
Capital invested by funds: $881M → $733M (-$147M)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
97% less call options, than puts
Call options by funds: $342K | Put options by funds: $13.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$9.25M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$6.99M |
| 3 |
BlackRock
New York
|
+$6.96M |
| 4 |
Morgan Stanley
New York
|
+$5.66M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$20.6M |
| 2 |
Millennium Management
New York
|
-$9.17M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.03M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.83M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.32M |
SPPI Hedge Fund Activity: Q2 2019 in Review
165 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2019, worth a combined $733M — down 17% from $881M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SPPI and 17 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 82 added.
The largest buyer was Renaissance Technologies, adding an estimated $9.25M. The largest seller was Armistice Capital, exiting entirely with an estimated $20.6M sold.
- 165 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2019, down from 173 in Q1 2019.
- Funds reported $733M of Spectrum Pharmaceuticals Inc stock for Q2 2019, down 17% quarter-over-quarter.
- 17 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of -6 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2019 was Renaissance Technologies, an estimated $9.25M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2019 was Armistice Capital, an estimated $20.6M sold.
Based on aggregated 13F filings for Q2 2019.